Clinical Trial Update: Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating a personalized neoantigen mRNA vaccine in combination with the PD-1 inhibitor adebrelimab for non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Personalized Neoantigen MRNA Vaccine

Snippet

Sponsor: Nanjing Tianyinshan Hospital | Conditions: NSCLC | EARLY_Phase 1 | Status: NOT_YET_RECRUITING